Literature DB >> 11510478

Modulation of gene expression by (-)-epigallocatechin gallate in PC-9 cells using a cDNA expression array.

S Okabe1, N Fujimoto, N Sueoka, M Suganuma, H Fujiki.   

Abstract

Green tea is the most effective cancer preventive beverage. In the light of this, the mechanisms of action of tea polyphenols were investigated on the molecular levels. We present here the effects of (-)-epigallocatechin gallate (EGCG) on expression of 588 genes in human lung cancer cell line PC-9 cells, using a human cancer cDNA expression array. The levels of gene expression in non-treated control cells, and cells treated with EGCG alone, with the tumor promoter okadaic acid alone, and with EGCG plus okadaic acid, were studied, and their expression levels were classified into down-regulation (under 0.5 fold) and up-regulation (over 2.0 fold) by comparing with the levels of control. Non-treated PC-9 cells expressed 163 genes out of 588, and EGCG-treated cells induced down-regulated expression of 12 genes and up-regulated expression of 4 other genes. From a comparison of gene expression in the cells treated with EGCG and in cells treated with EGCG plus okadaic acid, we found the following genes commonly affected by EGCG: down-regulation of four genes, NF-kappaB inducing kinase (NIK), death-associated protein kinase 1 (DAPK 1), rhoB and tyrosine-protein kinase (SKY); up-regulation of one gene, retinoic acid receptor alpha1. Among them, we think down-regulation of NIK gene expression is significant for cancer prevention, based on evidence that inhibition of NF-kappaB activation is a result of inhibition of NIK/IKK signalling complex.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11510478     DOI: 10.1248/bpb.24.883

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  8 in total

Review 1.  Synergistic enhancement of anticancer effects on numerous human cancer cell lines treated with the combination of EGCG, other green tea catechins, and anticancer compounds.

Authors:  Hirota Fujiki; Eisaburo Sueoka; Tatsuro Watanabe; Masami Suganuma
Journal:  J Cancer Res Clin Oncol       Date:  2014-12-28       Impact factor: 4.553

2.  Dietary soy and tea mitigate chronic inflammation and prostate cancer via NFκB pathway in the Noble rat model.

Authors:  Anna Hsu; Richard S Bruno; Christiane V Löhr; Alan W Taylor; Rodrick H Dashwood; Tammy M Bray; Emily Ho
Journal:  J Nutr Biochem       Date:  2011-05       Impact factor: 6.048

3.  Anti-inflammatory activity of soy and tea in prostate cancer prevention.

Authors:  Anna Hsu; Tammy M Bray; Emily Ho
Journal:  Exp Biol Med (Maywood)       Date:  2010-06

Review 4.  Challenging the effectiveness of green tea in primary and tertiary cancer prevention.

Authors:  Hirota Fujiki; Kazue Imai; Kei Nakachi; Masahito Shimizu; Hisataka Moriwaki; Masami Suganuma
Journal:  J Cancer Res Clin Oncol       Date:  2012-06-15       Impact factor: 4.553

5.  Chemoprevention of dibenzo[a,l]pyrene transplacental carcinogenesis in mice born to mothers administered green tea: primary role of caffeine.

Authors:  David J Castro; Zhen Yu; Christiane V Löhr; Clifford B Pereira; Jack N Giovanini; Kay A Fischer; Gayle A Orner; Roderick H Dashwood; David E Williams
Journal:  Carcinogenesis       Date:  2008-07-16       Impact factor: 4.944

6.  The modulation of endothelial cell gene expression by green tea polyphenol-EGCG.

Authors:  Liping Liu; Chao-Qiang Lai; Lin Nie; Jose Ordovas; Michael Band; Leta Moser; Mohsen Meydani
Journal:  Mol Nutr Food Res       Date:  2008-10       Impact factor: 5.914

7.  ArraySolver: an algorithm for colour-coded graphical display and Wilcoxon signed-rank statistics for comparing microarray gene expression data.

Authors:  Haseeb Ahmad Khan
Journal:  Comp Funct Genomics       Date:  2004

Review 8.  Molecular Insights into Potential Contributions of Natural Polyphenols to Lung Cancer Treatment.

Authors:  Qingyu Zhou; Hua Pan; Jing Li
Journal:  Cancers (Basel)       Date:  2019-10-15       Impact factor: 6.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.